{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:56:57Z","timestamp":1792785417974,"version":"4.5.0"},"reference-count":128,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82304301 to H.X."],"award-info":[{"award-number":["82304301 to H.X."]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhongshan Municipal Bureau of Science and Technology","award":["2023B2030 to H.X."],"award-info":[{"award-number":["2023B2030 to H.X."]}],"id":[{"id":"https:\/\/ror.org\/01b7ss333","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhongshan Institute for Drug Discovery","award":["ZIDD202302 to C.L."],"award-info":[{"award-number":["ZIDD202302 to C.L."]}]},{"name":"High-level new R&D institute","award":["2019B090904008"],"award-info":[{"award-number":["2019B090904008"]}]},{"name":"the High-level Innovative Research Institute","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}]},{"name":"the Guangdong Basic and Applied Basic Research Foundation","award":["2021B1515420002 to C.L."],"award-info":[{"award-number":["2021B1515420002 to C.L."]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.1080\/13543776.2025.2522747","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:17:52Z","timestamp":1750324672000},"page":"937-963","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["An updated patent review of TEAD modulators (2022\u2013present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Dounan","family":"Xu","sequence":"first","affiliation":[{"name":"Guangdong Pharmaceutical University","place":["Guangzhou, China"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Guangdong Pharmaceutical University","place":["Guangzhou, China"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]},{"name":"Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]},{"name":"Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]},{"name":"Zhuhai Campus of Zunyi Medical University","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[{"name":"Guangdong Pharmaceutical University","place":["Guangzhou, China"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]},{"name":"Southern Medical University","place":["Guangzhou, China"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xiong","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","place":["Zhongshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00075"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601630"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2008.02.006"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01191-9"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6423"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.40889"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.230425"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2017.09.003"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114684"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0717"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02219-9"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25246001"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000293107"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2022.12.005"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400361"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-LB319"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107809"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2036"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3168"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-1662"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-1656"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-4964"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/0113892002351556250123105344"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-7575"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124300"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2019.11.003"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.06.003"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.06.004"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00577-0"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.11.006"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3218"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz4589"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13771-5"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0371"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.02.010"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2096436"},{"key":"e_1_3_6_39_1","unstructured":"Vivace Therapeutics. Tertiary carboxamide compounds. WO2022087008A1 2022."},{"key":"e_1_3_6_40_1","unstructured":"Vivace Therapeutics. Compounds and methods of use thereof. WO2023146512A1 2023."},{"key":"e_1_3_6_41_1","unstructured":"Vivace Therapeutics. Compounds and methods of use thereof. WO2023146511A1 2023."},{"key":"e_1_3_6_42_1","unstructured":"Vivace Therapeutics. Compounds and methods of use thereof. WO2023146513A1 2023."},{"key":"e_1_3_6_43_1","unstructured":"Vivace Therapeutics. Phenyl phosphine oxide compounds and methods of use thereof. WO2023204822A1 2023."},{"key":"e_1_3_6_44_1","unstructured":"Vivace Therapeutics. Compounds and methods for treating cancer. WO2025034563A1 2025."},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.3c00122"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202200303"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300051"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00754-9"},{"key":"e_1_3_6_49_1","unstructured":"Novartis. Crystalline forms of biaryl yap\/taz-tead protein-protein interaction inhibitors. WO2023031799 2023."},{"key":"e_1_3_6_50_1","unstructured":"Novartis. Crystalline forms of a biaryl yap\/taz-tead protein-protein interaction inhibitor. WO2024176128A1 2024."},{"key":"e_1_3_6_51_1","unstructured":"Novartis. Bifunctional degraders comprising a tead binder. WO2023031801A1 2023."},{"key":"e_1_3_6_52_1","unstructured":"Ikena Oncology. Tead inhibitors and uses thereof. WO2022120353A1 2022."},{"key":"e_1_3_6_53_1","unstructured":"Ikena Oncology. Tead inhibitors and uses thereof. WO2022120354A1 2022."},{"key":"e_1_3_6_54_1","unstructured":"Ikena Oncology. Tead degraders and uses thereof. WO2022120355A1 2022."},{"key":"e_1_3_6_55_1","unstructured":"Ikena Oncology. Polymorphic compounds and uses thereof. WO2023211889A1 2023."},{"key":"e_1_3_6_56_1","unstructured":"Ikena Oncology. Tead inhibitors and uses thereof. WO2023114984A1 2023."},{"key":"e_1_3_6_57_1","unstructured":"Ikena Oncology. Tead inhibitors and uses thereof. WO2023060227A1 2023."},{"key":"e_1_3_6_58_1","unstructured":"Bridgene Biosciences. Yap\/taz-tead oncoproteins inhibitors. WO2024059317A1 2024."},{"key":"e_1_3_6_59_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. 2-pyrazole anilines and related analogs for inhibiting yap\/taz-tead. WO2023122780A2 2023."},{"key":"e_1_3_6_60_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Spiros and related analogs for inhibiting yap\/taz-tead. WO2023122784A2 2023."},{"key":"e_1_3_6_61_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Tetrahydrobenzoazepinones and related analogs for inhibiting yap\/taz-tead. WO2023122781A2 2023."},{"key":"e_1_3_6_62_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Indoles indazoles and related analogs for inhibiting yap\/taz-tead. WO2023122782A2 2023."},{"key":"e_1_3_6_63_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Tetrahydropyrazolopyrimidines and related analogs for inhibiting yap\/taz-tead. WO2023122783A2 2023."},{"key":"e_1_3_6_64_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Dihydroquinazolinones and related analogs for inhibiting yap\/taz-tead. WO2023164596A1 2023."},{"key":"e_1_3_6_65_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Tetrahydropyridopyrimidines and related analogs for inhibiting YAP\/TAZ-TEAD and their preparation. WO2023150619A2 2023."},{"key":"e_1_3_6_66_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Benzopiperazine analogs as YAP\/TAZ-TEAD transcription inhibitors and their preparation pharmaceutical compositions and use in the treatment of diseases. WO2024238765A2 2024."},{"key":"e_1_3_6_67_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Imidazo[1 5-a]pyridine compounds as YAP\/TAZ-TEAD inhibitors and their preparation pharmaceutical compositions and use in the treatment of cancer fibrosis and congenital disorders. WO2024238738A2 2024."},{"key":"e_1_3_6_68_1","unstructured":"The Katholieke Universiteit Leuven SpringWorks Therapeutics. Tetrahydronaphthyridine and related analogs for inhibiting YAP\/TAZ-TEAD and their preparation. WO2024238763A2 2024."},{"key":"e_1_3_6_69_1","unstructured":"Insilico Medicine. Novel heterocyclic compounds as TEAD inhibitors. CN116425670A 2023."},{"key":"e_1_3_6_70_1","unstructured":"Insilico Medicine. Tead inhibitors and methods of uses thereof. WO2024067773A1 2024."},{"key":"e_1_3_6_71_1","unstructured":"Insilico Medicine. Heterocyclic compound and pharmaceutical composition and application thereof. CN115925688A 2023."},{"key":"e_1_3_6_72_1","unstructured":"Merck. Aryl ether compounds as tead modulators. WO2022177869A1 2022."},{"key":"e_1_3_6_73_1","unstructured":"Merck. Tricyclic heterocycles. WO2023072974A1 2023."},{"key":"e_1_3_6_74_1","unstructured":"Merck. 2 8-dihydropyrazolo[3 4-b]indole derivatives for use in the treatment of cancer. WO2022233442A1 2022."},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00403"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01949"},{"key":"e_1_3_6_77_1","unstructured":"Merck. Substitued bicyclic heterocyclic yap-tead and\/or taz-tead inhibitors. WO2025026997A1 2025."},{"key":"e_1_3_6_78_1","unstructured":"Merck. Heterobifunctional molecules as tead inhibitors. WO2023078813A1 2023"},{"key":"e_1_3_6_79_1","unstructured":"Genentech. Therapeutic indazole compounds and methods of use in the treatment of cancer. WO2023097195A1 2023."},{"key":"e_1_3_6_80_1","unstructured":"Genentech. Therapeutic compounds and methods of use. WO2023097194A2 2023."},{"key":"e_1_3_6_81_1","unstructured":"Opna Bio SA. Compounds and methods for yap\/tead modulation and indications therefor. WO2024159103A1 2024."},{"key":"e_1_3_6_82_1","unstructured":"Opna Bio SA. Compounds and methods for yap\/tead modulation and indications therefor. WO2023147063A2 2023."},{"key":"e_1_3_6_83_1","unstructured":"Opna Bio SA. Compounds and methods for yap\/tead modulation and indications therefor. WO2024159079A1 2024."},{"key":"e_1_3_6_84_1","unstructured":"Opna Bio SA. Compounds and methods for yap\/tead modulation and indications therefor. WO2024159081A1 2024."},{"key":"e_1_3_6_85_1","unstructured":"Opna Bio SA. Compounds and methods for yap\/tead modulation and indications therefor. WO2024159088A1 2024."},{"key":"e_1_3_6_86_1","unstructured":"Opna Bio SA. Compounds and methods for yap\/tead modulation and indications therefor. WO2024159067A1 2024."},{"key":"e_1_3_6_87_1","unstructured":"Cedilla Therapeutics. Tead inhibitors and uses thereof. WO2022204452A1 2022."},{"key":"e_1_3_6_88_1","unstructured":"Cedilla Therapeutics. Tead inhibitors and uses thereof. WO2022272036A1 2022."},{"key":"e_1_3_6_89_1","unstructured":"Cedilla Therapeutics. Tead inhibitors and uses thereof. WO2023009785A1 2023."},{"key":"e_1_3_6_90_1","unstructured":"Humanwell Healthcare. Heterocyclic compounds as TEAD inhibitors. CN116332922A 2023."},{"key":"e_1_3_6_91_1","unstructured":"Humanwell Healthcare. Heterocyclic compounds for TEAD inhibitors. CN115466243A 2022."},{"key":"e_1_3_6_92_1","unstructured":"Humanwell Healthcare. TEAD inhibitors. CN118005606A 2024."},{"key":"e_1_3_6_93_1","unstructured":"Humanwell Healthcare. Tead inhibitor. WO2023280254A1 2023."},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2018.11.010"},{"key":"e_1_3_6_95_1","unstructured":"The Scripps Research Institute. Small molecule inhibitors of tea domain family members. WO2023183768A2 2023."},{"key":"e_1_3_6_96_1","unstructured":"Sporos Biodiscovery. Tead inhibitors and methods of use. WO2024020350A1 2024."},{"key":"e_1_3_6_97_1","unstructured":"Dana-Farber Cancer Institute. Transcriptional enhanced associated domain (tead) transcription factor inhibitors and uses thereof. WO2022232088A1 2022."},{"key":"e_1_3_6_98_1","unstructured":"Light Horse Therapeutics. Heterocyclic tead inhibitors. WO2024091511A1 2024."},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01548"},{"key":"e_1_3_6_100_1","unstructured":"Bayer. Tead inhibitors. WO2024003259A1 2024."},{"key":"e_1_3_6_101_1","unstructured":"Orion Corporation. Tead inhibitors. WO2022219246A1 2022."},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80210"},{"key":"e_1_3_6_103_1","unstructured":"The General Hospital Corporation. Small molecule inhibitors of tead-yap. WO2023049808A2 2023."},{"key":"e_1_3_6_104_1","unstructured":"Scinnohub pharmaceutical co. ltd. Compound for regulating tead activity preparation method therefor and use thereof. WO2024255856A1 2024."},{"key":"e_1_3_6_105_1","unstructured":"Signet Therapeutics. Heteroaromatic compounds and uses thereof. CN118420607A 2024."},{"key":"e_1_3_6_106_1","unstructured":"Signet Therapeutics. Tricyclic compound and application thereof. WO2023143354A1 2023."},{"key":"e_1_3_6_107_1","unstructured":"Hengrui Pharmaceuticals. Indazole compound preparation method therefor and use thereof in medicine. WO2023186058A1 2023."},{"key":"e_1_3_6_108_1","unstructured":"Jiesi Yingda Pharmaceutical Technology. Tead inhibitor preparation method therefor. and medical use thereof. WO2024120519A1 2024."},{"key":"e_1_3_6_109_1","unstructured":"TYK Medicines. Polycyclic compound and use thereof. WO2023016562A1 2023."},{"key":"e_1_3_6_110_1","unstructured":"TYK Medicines. Polycyclic compound and use thereof. CN116425757A 2023."},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01393"},{"key":"e_1_3_6_112_1","unstructured":"BAOBAB AIBIOCO. Heterobicyclic compound and pharmaceutical composition comprising same. WO2024019562A1 2024."},{"key":"e_1_3_6_113_1","unstructured":"BAOBAB AIBIOCO. Heterobicyclic compound and pharmaceutical composition comprising same. WO2024210578A1 2024."},{"key":"e_1_3_6_114_1","unstructured":"Sporos Biodiscovery. Tead inhibitors and methods of use. WO2023183437A1 2023."},{"key":"e_1_3_6_115_1","unstructured":"Dong-A St Co. Bicycle compounds as tead inhibitor. WO2023209651A1 2023"},{"key":"e_1_3_6_116_1","unstructured":"SAMJIN Pharmaceutical. Novel benzoindolone compounds and pharmaceutical composition comprising same. WO2022249120A1 2022."},{"key":"e_1_3_6_117_1","unstructured":"The Board Of Trustees Of The Leland Stanford Junior University. Transcriptional enhanced associate domain (tead) degraders and uses thereof. WO2023154811A2 2023."},{"key":"e_1_3_6_118_1","unstructured":"Shanghai Jiao Tong University. Preparation of pyrazolamide derivatives for targeted degradation of TEAD and application thereof. CN118546122A 2024."},{"key":"e_1_3_6_119_1","unstructured":"Beactica Therapeutics Ab. Aromatic amides and conjugates thereof as binders to tead. WO2024240840A1 2024."},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02884"},{"key":"e_1_3_6_121_1","unstructured":"Hengrui Pharmaceuticals. Fused tetracyclic compound preparation method thereof and application thereof in medicines. CN117700420A 2024."},{"key":"e_1_3_6_122_1","unstructured":"Etern Biopharma. Inhibitor of interaction between yap\/taz and tead preparation thereof pharmaceutical composition thereof and use thereof. WO2023155927A1 2023."},{"key":"e_1_3_6_123_1","unstructured":"Etern Biopharma. Tricyclic compound preparation therefor pharmaceutical composition and use. WO2023137634A1 2023."},{"key":"e_1_3_6_124_1","unstructured":"Novartis. Tead and kras g12d-inhibitor combinations for treating cancer. WO2024176131A1 2024."},{"key":"e_1_3_6_125_1","unstructured":"Novartis. Pharmaceutical combinations comprising a tead inhibitor and uses thereof for the treatment of cancers. WO2023031781A1 2023."},{"key":"e_1_3_6_126_1","unstructured":"Novartis. Tead and her2-inhibitor combinations for treating cancer. WO2024176130A1 2024."},{"key":"e_1_3_6_127_1","unstructured":"Ikena Oncology. Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and\/or mek inhibitor for use in the treatment of lung cancer. WO2022159986A1 2024."},{"key":"e_1_3_6_128_1","unstructured":"Ikena Oncology. Combination of tead inhibitors and egfr inhibitors and uses thereof. WO2024092116A1 2024."},{"key":"e_1_3_6_129_1","unstructured":"Sanofi. Therapeutic combination of kras g12c inhibitor and tead inhibitor. WO2023194310A1 2023."},{"key":"e_1_3_6_130_1","unstructured":"Genentech. Combination therapy. WO2022246459A1 2022."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2522747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2025.2522747","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2522747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:40:36Z","timestamp":1790865636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2522747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":128,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,3]]}},"alternative-id":["10.1080\/13543776.2025.2522747"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2522747","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}